Pearl River Capital’s Natus Medical Inc NTUS Stock Holding History

Pearl River Capital’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-894	Closed	-$30K	–	903
2018 Q4	$30K	Buy	+894	New	+$29.1K	0.14%	198

Other funds holding NTUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Pearl River Capital's NTUS Position: Q1 2019 in Review

Pearl River Capital sold out of Natus Medical Inc (NTUS) in Q1 2019, closing a stake of 894 shares — an estimated $30K sold.

Pearl River Capital first reported a position in NTUS in Q4 2018 and held it in 1 quarter. The position peaked at $30K in Q4 2018. 168 funds tracked by Wall St. Rank hold NTUS as of Q1 2019.

Pearl River Capital reported no remaining Natus Medical Inc position as of Q1 2019 after selling out during the quarter.
Pearl River Capital sold 894 Natus Medical Inc shares in Q1 2019, an estimated $30K.
Pearl River Capital first reported a position in Natus Medical Inc in Q4 2018 and held it in 1 quarter.
Pearl River Capital's Natus Medical Inc position peaked at $30K in Q4 2018.
168 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2019.

Based on Pearl River Capital's 13F filing for Q1 2019, filed 2 May 2019.